by CEG Email | Mar 11, 2021 | News
Training Level: Provider Thursday, March 18th, 2021 from 2:00 – 3:00 PM Eastern VEKLURY® (remdesivir) is the first and only antiviral approved for the treatment of patients requiring hospitalization for COVID-19. Join us to find out more information on when and... by CEG Email | Mar 2, 2021 | News
In Case You Missed It: When it comes to COVID vaccines, we all have unanswered questions. On Thursday, February 25th, 2021, Dr. Nabarun Dasgupta, a side effect scientist at the University of North Carolina, provided plain language interpretations of the approval... by CEG Email | Feb 26, 2021 | News
Training Level: Community & Organizational Thursday, March 4th, 2021 from 2:00 – 3:00 PM Eastern Learning Objectives:• Understand the progress HIV treatments have made since 1981, resulting in more people living longer with HIV• Educate people with HIV about... by CEG Email | Feb 19, 2021 | News
Training Level: Community & Organizational Thursday, February 25th, 2021 from 2:00 – 3:00 PM Eastern When it comes to COVID vaccines, we all have unanswered questions.Dr. Nabarun Dasgupta is a side effect scientist at the University of North Carolina. He... by CEG Email | Feb 12, 2021 | News
Training Level: Community & Organizational Thursday, February 18th, 2021 from 2:00 – 3:00 PM Eastern The Basics of Hepatitis B Learning Objectives: • Prevalence of Hepatitis B • Hepatitis B Prevention • Population at Risk, Screening, and Linkage to Care This...
Recent Comments